Align Technology Inc AFW
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AFW is a good fit for your portfolio.
News
-
Fewer dentist visits hit Invisalign maker Align last year. Here's why the stock is rallying now.
-
Align Technology to buy back $100 million of its common stock
-
Invisalign maker Align Technology's stock bounces, as $250 million ASR announced following a 25% price plunge
-
Invisalign maker's stock craters after soft earnings, but analysts still say it's a buy
-
Nine stocks in the Nasdaq-100 have dropped 15% or more during October
-
Consumers are cutting back on dental visits, and that's hammering this stock
-
Does anyone want to buy bankrupt SmileDirectClub?
-
Align earnings top expectations as teens and other customers drive growth
Trading Information
- Previous Close Price
- $291.80
- Day Range
- $288.30–288.30
- 52-Week Range
- —–619.20
- Bid/Ask
- $290.40 / $291.20
- Market Cap
- $21.70 Bil
- Volume/Avg
- 0 / 16
Key Statistics
- Price/Earnings (Normalized)
- 36.71
- Price/Sales
- 6.15
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.39%
Company Profile
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 21,610
- Website
- https://www.aligntech.com
Competitors
Valuation
|
Metric
|
AFW
|
XRAY
|
STMN
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.71 | 16.86 | 47.95 |
Price/Book Value | 6.31 | 1.94 | 11.99 |
Price/Sales | 6.15 | 1.65 | 9.14 |
Price/Cash Flow | 39.23 | 14.04 | 38.07 |
Price/Earnings
AFW
XRAY
STMN
Financial Strength
|
Metric
|
AFW
|
XRAY
|
STMN
|
|---|---|---|---|
Quick Ratio | 0.98 | 0.76 | 1.34 |
Current Ratio | 1.18 | 1.38 | 1.95 |
Interest Coverage | — | −1.16 | 19.50 |
Quick Ratio
AFW
XRAY
STMN
Profitability
|
Metric
|
AFW
|
XRAY
|
STMN
|
|---|---|---|---|
Return on Assets (Normalized) | 10.84% | 3.62% | 13.05% |
Return on Equity (Normalized) | 18.16% | 7.63% | 23.67% |
Return on Invested Capital (Normalized) | 17.22% | 5.75% | 18.17% |
Return on Assets
AFW
XRAY
STMN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jlfqnctqd | Ngbmdkb | $185.4 Bil | |
SYK
| Stryker Corp | Wmqqlltr | Mjjqx | $127.7 Bil | |
BSX
| Boston Scientific Corp | Lgsxmkkwr | Mdfxyf | $107.6 Bil | |
MDT
| Medtronic PLC | Pmtqbxhb | Zjbvkc | $105.9 Bil | |
DXCM
| DexCom Inc | Lhhpcnkdp | Yby | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Dpbpvnqjp | Xrbgg | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jvfcmvvtn | Chbs | $24.6 Bil | |
ALGN
| Align Technology Inc | Cxdlzwvn | Prywj | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Hbqcbrfd | Crdphqs | $18.7 Bil | |
PODD
| Insulet Corp | Lmxbhbmrj | Vrgstp | $11.6 Bil |